Six-year mortality rates of patients in methadone and buprenorphine maintenance therapy: Results from a nationally representative cohort study

Journal of Clinical Psychopharmacology

Volumn 31, Issue 5, 2011, Pages 678-680

  Soyka, Michael ^a,b   Träder, Anna ^c   Klotsche, Jens ^c   Backmund, Markus ^d   Bühringer, Gerhard ^c   Rehm, Jürgen ^e   Wittchen, Hans Ulrich ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b Private Hospital Meiringen   (Switzerland)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d Praxiszentrum im Tal   (Germany)

^e CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE;

ADDICTION SEVERITY INDEX; ADULT; CAUSE OF DEATH; DISEASE SEVERITY; DRUG DEPENDENCE TREATMENT; FEMALE; FOLLOW UP; HUMAN; LETTER; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MORTALITY; OPIATE ADDICTION; PRIORITY JOURNAL; RATING SCALE; TREATMENT OUTCOME;

ADULT; BUPRENORPHINE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; METHADONE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PROSPECTIVE STUDIES;

EID: 80052487056     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31822cd446     Document Type: Letter

References (16)

1. Hser YI, Anglin DA, Powers K. A 24-year follow-up of California narcotic addicts. Arch Gen Psychiatry. 1993;50:577-584. (Pubitemid 23203568)
2. Bjornaas MA, Bekken AS, Ojlert A, et al. A 20-year prospective study of mortality and causes of death among hospitalized opioid addicts in Oslo. BMC Psychiatry. 2008;8:8.
3. Peles E, Schreiber S, Adelson M. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel. Drug Alcohol Depend. 2010;107:141-148.
4. Degenhardt L, Randall D, Hall W, et al. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend. 2009;105:9-15.
5. Mattick RP, Breen C, Kimber J, et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;3:CD002209.
6. Degenhardt L, Bucello C, Mathers B, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2010;106:32-51.
7. Soyka M, Apelt SM, Lieb M, et al. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients. J Clin Psychopharmacol. 2006;26:657-660. (Pubitemid 44772746)
8. Wittchen HU, Apelt SM, Soyka M, et al. Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients. Drug Alcohol Depend. 2008;95:245-257.
9. Gsellhofer B, Küfner H, Vogt M, et al. European Addiction Severity. Index-EuropASI. Manual for Training and Execution. Stuttgard: Schneider Verlag; 1999.
10. Bell J, Trinh L, Butler B, et al. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment. Addiction. 2009;104:1193-1200.
11. Soyka M, Penning C, Wittchen H-U. Fatal poisoning in methadone and buprenorphine treated patientsVare there differences? Pharmacopsychiatry. 2006;39:85-87. (Pubitemid 43901619)
12. Pirnay S, Borron SW, Giudicelli CP, et al. A critical reviewof the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction. 2004;99:978-988. (Pubitemid 39452810)
13. Cornish R, Macleod J, Strang J, et al. Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database. BMJ. 2010;341:c5475.
14. Lieb M, Wittchen H-U, Palm U, et al. Psychiatric comorbidity in substitution treatment of opioid dependent patients in primary care: prevalence and impact on clinical features. Heroin Addict Relat Clin Probl. 2010;12:5-16.
15. McCowan C, Kidd B, Fahey T. Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study. BMJ. 2009; 338:b2225.
16. Kimber J, Copeland L, Hickman, et al. Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment. BMJ. 2010;341:c3172.